Disassembly of nuclear inclusions in the dividing cell - A novel insight into neurodegeneration

Human Molecular Genetics

Volumn 8, Issue 13, 1999, Pages 2451-2459

  Rich, Tina ^a   Assier, Eric ^b   Skepper, Jeremy ^a   Segard, Haniaa B ^b   Allen, Rachel L ^a   Charron, Dominique ^b   Trowsdale, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CELL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL NUCLEUS INCLUSION BODY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT;

ANIMALIA;

EID: 0032714557     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/8.13.2451     Document Type: Article

References (42)

1. Ross, C.A. (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron, 19, 1147-1150.
2. Perutz, M.F. (1996) Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr. Opin. Struct. Biol., 6, 848-858.
3. Gerber, H.P., Seipel, K., Georgiev, O., Hofferer, M., Hug, M., Rusconi, S. and Schaffner, W. (1994) Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science, 263, 808-811.
4. MacLean, H.E., Warne, G.L. and Zajac, J.D. (1996) Spinal and bulbar muscular atrophy: androgen receptor dysfunction caused by a trinucleotide repeat expansion. J. Neurol. Sci., 135, 149-157.
5. Sisodia, S.S. (1998) Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell, 95, 1-4.
6. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
7. Price, D.L., Becher, M.W., Wong, P.C., Borchelt, D.R. Lee, M.K. and Sisodia, S.S. (1996) Inherited neurodegenerative diseases and transgenic models. Brain Pathol., 6, 467-480.
8. Bates, G.P., Mangiarini, L. and Davies, S.W. (1998) Transgenic mice in the study of polyglutamine repeat expansion diseases. Brain Pathol., 8, 699-714.
9. Stott, K., Blackburn, J.M., Butler, P.J. and Perutz, M. (1995) Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc. Natl Acad. Sci. USA, 92, 6509-6513.
10. Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G.P., Lehrach, H. and Wanker, E.E. (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl Acad. Sci. USA, 96, 4604-4609.
11. Assier, E., Bouzinba-Segard, H., Stolzenberg, M., Stephens, R., Bardos, J., Freemont, P., Charron, D., Trowsdale, J. and Rich, T. (1999) Isolation, sequencing and expression of RED, a novel human gene encoding an acidic-basic dipeptide repeat. Gene, 230, 145-154.
12. Levinson, G. and Gutman, G.A. (1987) Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol., 4, 203-221.
13. Onodera, O., Oyake, M., Takano, H., Ikeuchi, T., Igarashi, S. and Tsuji, S. (1995) Molecular cloning of a full-length cDNA for dentatorubral-pallidoluysian atrophy and regional expressions of the expanded alleles in the CNS. Am. J. Hum. Genet., 57, 1050-1060.
14. Perutz, M.F. (1995) Polar zippers: their role in human disease. Pharm. Acta Helv., 69, 213-224.
15. Chen, Y.W., Stott, K. and Perutz, M.F. (1999) Crystal structure of a dimeric chymotrypsin inhibitor 2 mutant containing an inserted glutamine repeat. Proc. Natl Acad. Sci. USA, 96, 1257-1261.
16. Pelsue, S. and Agris, P.F. (1994) Immunoreactivity between a monoclonal lupus autoantibody and the arginine/aspartic acid repeats within the U1-snRNP 70K autoantigen is conformationally restricted. J. Protein Chem., 13, 401-408.
17. Szostecki, C., Guldner, H., Netter, H. and Will, H. (1990) Isolation and characterisation of cDNA encoding a human nuclear antigen predominantly recognised by autoantibodies from patients with primary biliary cirrhosis. J. Immunol., 145, 4338-4347.
18. Skinner, P.J., Koshy, B.T., Cummings, C.J., Klement, I.A., Helin, K., Servadio, A., Zoghbi, H.Y. and Orr, H.T. (1997) Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature, 389, 971-974.
19. Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol., 143, 1457-1470.
20. Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G.P., Lehrach, H. and Wanker, E.E. (1998) SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell, 2, 427-436.
21. Matilla, A., Koshy, B.T., Cummings, C.J., Isobe, T., Orr, H.T. and Zoghbi, H.Y. (1997) The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature, 389, 974-978.
22. Lunkes, A. and Mandel, J.L. (1998) A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet., 7, 1355-1361.
23. Shinoda, K., Mori, S., Ohtsuki, T. and Osawa, Y. (1992) An aromatase-associated cytoplasmic inclusion, the 'stigmoid body', in the rat brain: I. Distribution in the forebrain. J. Comp. Neurol., 322, 360-376.
24. Gutekunst, C.A., Li, S.H., Yi, H., Ferrante, R.J., Li, X.J. and Hersch, S.M. (1998) The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J. Neurosci., 18, 7674-7686.
25. Li, S.H., Gutekunst, C.A., Hersch, S.M. and Li, X.J. (1998) Association of HAP1 isoforms with a unique cytoplasmic structure. J. Neurochem., 71, 2178-2185.
26. Beck, K. and Brodsky, B. (1998) Supercoiled protein motifs: the collagen triple-helix and the alpha-helical coiled coil. J. Struct. Biol., 122, 17-29.
27. Lupas, A. (1996) Coiled coils: new structures and new functions. Trends Biochem. Sci., 21, 375-382.
28. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 95, 41-53.
29. Sternsdorf, T., Grotzinger, T., Jensen, K. and Will, H. (1997) Nuclear dots: actors on many stages, Immunobiology, 198, 307-331.
30. Gregori, L., Fuchs, C., Figueiredo-Pereira, M., Van Nostrand, W. and Goldgaber, D. (1995) Amyloid β-protein inhibits ubiquitin-dependent protein degradation in vitro. J. Biol. Chem., 270, 19702-19708.
31. Perutz, M.F. (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci., 24, 58-63.
32. Kelly, J.W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol., 8, 101-106.
33. Onodera, O., Burke, J.R., Miller, S.E., Hester, S., Tsuji, S., Roses, A.D. and Strittmatter, W.J. (1997) Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells. Biochem. Biophys. Res. Commun., 238, 599-605.
34. Cooper, J.K., Schilling, G., Peters, M.F., Herring, W.J., Sharp, A.H., Kaminsky, Z., Masone, J., Khan, F.A., Delanoy, M., Borchelt, D.R., Dawson, V.L., Dawson, T.M. and Ross, C.A. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet., 7, 783-790.
35. Li, S.H. and Li, X.J. (1998) Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet., 7, 777-782.
36. Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., Bertaux, F., Wanker, E.E., Doherty, P., Davies, S.W. and Bates, G.P. (1999) Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet., 8, 813-822.
37. Johnston, J., Ward, C. and Kopito, R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol., 143, 1883-1898.
38. Nagai, Y., Onodera, O., Chun, J., Strittmatter, W.J. and Burke, J.R. (1999) Expanded polyglutamine domain proteins bind neurofilament and alter the neurofilament network. Exp. Neurol., 155, 195-203.
39. Gueth-Hallonet, C., Wang, J., Harborth, J., Weber, K. and Osborn, M. (1998) Induction of a regular nuclear lattice by overexpression of NuMA. Exp. Cell Res., 243, 434-452.
40. Saredi, A., Howard, L. and Compton. D.A. (1996) NuMA assembles into an extensive filamentous structure when expressed in the cell cytoplasm. J. Cell Sci., 109, 619-630.
41. Wang, Z.G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R. and Pandolfi, P.P. (1998) PML is essential for multiple apoptotic pathways. Nature Genet., 20, 266-272.
42. Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J.C. and de The, H. (1998) PML induces a novel caspase-independent death process. Nature Genet., 20, 259-265.